Structure of an unliganded simian immunodeficiency virus gp120 core

Nature

Volumn 433, Issue 7028, 2005, Pages 834-841

  Chen, Bing ^a   Vogan, Erik M ^a,b   Gong, Haiyun ^a   Skehel, John J ^c   Wiley, Don C ^a,b   Harrison, Stephen C ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; CELLS; CONFORMATIONS; CRYSTAL STRUCTURE; PROTEINS;

ANTIGENIC SURFACES; ANTIGENICS; GLYCOPROTEINS; SIMIAN IMMUNODEFICIENCY VIRUS (SIV);

VIRUSES;

CD4 ANTIGEN; ENVELOPE PROTEIN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; GP120 PROTEIN, SIMIAN IMMUNODEFICIENCY VIRUS; LIGAND; MEMBRANE PROTEIN; POLYSACCHARIDE; VIRUS ENVELOPE PROTEIN; VIRUS RECEPTOR;

MEDICINE;

ANTIGEN BINDING; ANTIGEN DETECTION; BINDING SITE; CONFORMATION; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; HOST CELL; HUMAN IMMUNODEFICIENCY VIRUS; MEMBRANE FUSION; NONHUMAN; OPTICAL RESOLUTION; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ENVELOPE; VIRUS INHIBITION; AMINO ACID SEQUENCE; ARTICLE; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; CRYSTALLIZATION; DRUG EFFECT; GLYCOSYLATION; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN BINDING; PROTEIN QUATERNARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; VIRION; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANTIGENS, CD4; BINDING SITES; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; GLYCOSYLATION; LIGANDS; MEMBRANE GLYCOPROTEINS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; POLYSACCHARIDES; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL ENVELOPE PROTEINS; VIRION;

EID: 13844302894     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03327     Document Type: Review

References (50)

1. Wyatt, R. & Sodroski, J. The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens. Science 280, 1884-1888 (1998).
2. Allan, J. S. et al. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science 228, 1091-1094 (1985).
3. Veronese, F. D. et al. Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. Science 229, 1402-1405 (1985).
4. Center, R. J. et al. Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface. J. Virol. 76, 7863-7867 (2002).
5. Dalgleish, A. G. et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763-767 (1984).
6. Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877 (1996).
7. Trkola, A. et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384, 184-187 (1996).
8. Wu, L. et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384, 179-183 (1996).
9. Sattentau, Q. J. & Moore, J. P. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174, 407-415 (1991).
10. Sattentau, Q. J., Moore, I. P., Vignaux, F., Traincard, F. & Poignard, P. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J. Virol. 67, 7383-7393 (1993).
11. Rizzuto, C. D. et al A conserved HIV gpl20 glycoprotein structure involved in chemokine receptor binding. Science 280, 1949-1953 (1998).
12. Chan, D. C., Fass, D., Berger, J. M. & Kim, P. S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89, 263-273 (1997).
13. Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J. & Wiley, D. C. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387, 426-430 (1997).
14. Kwong, P. D. et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648-659 (1998).
15. Chan, D. C., Chutkowski, C. T. & Kim, P. S. Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target. Proc. Natl Acad. Sci. USA 95, 15613-15617 (1998).
16. Rimsky, L. T., Shugars, D. C. & Matthews, T. J. Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides. J. Virol. 72, 986-993 (1993).
17. Wyatt, R. et al. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393, 705-711 (1998).
18. Pollard, S. R., Meier, W., Chow, P., Rosa, J. J. & Wiley, D. C. CD4-binding regions of human immunodeficiency virus envelope glycoprotein gp120 defined by proteolytic digestion. Proc. Natl Acad. Sci. USA 88, 11320-11324 (1991).
19. Wyatt, R. et al. Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions. J. Virol. 67, 4557-4565 (1993).
20. Rud, E. W. et al. in Vaccines 92: Modern Approaches to New Vaccines Including Prevention of AIDS (eds Brown, F., Chanock, R. M., Ginsberg, H. S. & Lerner, R A.) 229-235 (Cold Spring Harbor Laboratory., New York, 1992).
21. Chen, B., Vogan, E., Gong, H. Y., Wiley, D. C. & Harrison, S. C. Determining the structure of an unliganded and fully-glycosylated SIV gp120 envelope glycoprotein. Structure (Camb.) (in the press).
22. Kwong, P. D. et al. Probability analysis of variational crystallization and its application to gp120, the exterior envelope glycoprotein of type 1 human immunodeficiency virus (HIV-1). J. Biol. Chem. 274, 4115-4123 (1999).
23. Thali, M. et al. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67, 3978-3988 (1993).
24. Lin, P. F. et al. A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding. Proc. Natl Acad. Sci. USA 100, 11013-11018 (2003).
25. Moore, J. P. & Sodroski, I. Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein. J. Virol. 70, 1863-1872 (1996).
26. Myszka, D. G. et al. Energetics of the HIV gp120-CD4 binding reaction. Proc. Natl Acad. Sci. USA 97, 9026-9031 (2000).
27. Kwong, P. D. et al. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 420, 678-682 (2002).
28. Burton, D. R. et al. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266, 1024-1027 (1994).
29. Pantophlet, R. et al. Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120. J. Virol. 77, 642-658 (2003).
30. Etemad-Moghadam, B. et al. Characterization of simian-human immunodeficiency virus envelope glycoprotein epitopes recognized by neutralizing antibodies from infected monkeys. J. Virol. 72, 8437-8445 (1998).
31. Zwick, M. B. et al. A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12. J. Virol. 77, 6965-6978 (2003).
32. Guo, Q. et al. Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions. J. Virol. 77, 10528-10536 (2003).
33. Madani, N. et al. Localized changes in the gp120 envelope glycoprotein confer resistance to human immunodeficiency virus entry inhibitors BMS-806 and #155. J. Virol. 78, 3742-3752 (2004).
34. Ferrer, M. & Harrison, S. C. Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries. J. Virol. 73, 5795-5802 (1999).
35. Chen, B. et al. A chimeric protein of simian immunodeficiency virus envelope glycoprotein gp140 and Escherichia coli aspartate transcarbamoylase. J. Virol. 78, 4508-4516 (2004).
36. Moore, J. P., McKeating, J. A., Weiss, R. A. & Sattentau, Q. J. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250, 1139-1142 (1990).
37. Pugach, P. et al. The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4. Virology 321, 8-22 (2004).
38. Puffer, B. A., Altamura, L. A., Pierson, T. C. & Doms, R. W. Determinants within gp120 and gp4l contribute to CD4 independence of SIV Envs. Virology 327, 16-25 (2004).
39. Kolchinsky, P., Kiprilov, E. & Sodroski, I. Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants. J. Virol. 75, 2041-2050 (2001).
40. Puffer, B. A. et al. CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity. J. Virol. 76, 2595-2605 (2002).
41. Turner, S. et al. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120. Proc. Natl Acad. Sci. USA 89, 1335-1339 (1992).
42. Kwong, P. D., Wyatt, R., Sattentau, Q. J., Sodroski, I. & Hendrickson, W. A. Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus. J. Virol. 74, 1961-1972 (2000).
43. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
44. Terwilliger, T. C. & Berendzen, J. Automated MAD and MIR structure solution. Acta Crystallogr. D Biol. Crystallogr. 55, 849-861 (1999).
45. de la Fortelle, E. & Bricogne, G. Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. Methods Enzymol. 276, 472-493 (1997).
46. Collaborative Computational Project, N. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760-763 (1994).
47. Brunger, A. T. et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905-921 (1998).
48. Jones, T. A., Zou, J. Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119 (1991).
49. McDonald, I. K. & Thornton, J. M. Satisfying hydrogen bonding potential in proteins. J. Mol. Biol. 238, 777-793 (1994).
50. Wallace, A. C., Laskowski, R. A. & Thornton, J. M. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8, 127-134 (1995).